Chair(s)
Lectures of the session
11:40
Assessing the safety of adipose-derived cell products: perspectives from a company developing products in both the EU and USA
12:00
11:40
Assessing the safety of adipose-derived cell products: perspectives from a company developing products in both the EU and USA
12:00